β3-Adrenoceptors in the heart

Cardiovascular Research

Volumn 56, Issue 3, 2002, Pages 353-356

  Conrath, Chantal E ^a   Opthof, Tobias ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADRENERGIC STIMULATION; BRONCHODILATATION; CYSTIC FIBROSIS; DEPOLARIZATION; EDITORIAL; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART INFARCTION; HEART RATE; HEMODYNAMICS; HUMAN; MEMBRANE CURRENT; MEMBRANE POTENTIAL; MOLECULAR EVOLUTION; PRIORITY JOURNAL; QT INTERVAL; QUANTITATIVE ANALYSIS; VASOCONSTRICTION; VOLTAGE CLAMP; ANIMAL; CELL MEMBRANE POTENTIAL; CONGESTIVE HEART FAILURE; EVOLUTION; GUINEA PIG; HEART; HEART MUSCLE CELL; NOTE; PHYSIOLOGY;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; EVOLUTION; GUINEA PIGS; HEART; HEART FAILURE, CONGESTIVE; HUMANS; MEMBRANE POTENTIALS; MYOCYTES, CARDIAC; RECEPTORS, ADRENERGIC, BETA-3;

EID: 0036882122     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00706-X     Document Type: Editorial

References (24)

1. Gauthier C., Tavernier G., Charpentier F., Langin D., Le Marec H. Functional beta3-adrenoceptor in the human heart. J Clin Invest. 98:1996;556-562.
2. 3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation. 103:2001;1649-1655.
3. Kitamura T., Onishi K., Dohi K., Okinaka T., Isaka N., Nakano T. The negative inotropic effect of beta3-adrenoceptor stimulation in the beating guinea pig heart. J Cardiovasc Pharmacol. 35:2000;786-790.
4. Ks in guinea pig ventricular myocytes. Cardiovasc Res. 56:2002;393-403.
5. Ks blockade at high heart rate in guinea pig and rabbit. Circulation. 104:2001;951-956.
6. 2-adrenoceptors with Gi in rat adipocytes. Cell Signal. 6:1994;457-465.
7. Strosberg A.D. Structure, function and regulation of adrenergic receptors. Protein Sci. 2:1993;1198-1209.
8. Chang H.J., Zhang Z.S., Onishi K., Tomohiku U., Sane D.C., Cheng C.P. Upregulation of functional β3-adrenergic receptor in the failing canine myocardium. Circ Res. 89:2001;599-606.
9. Leblais V., Demolombe S., Vallette G., et al. Beta3-adrenoceptor control of the cystic fibrosis transmembrane conductance regulator through a cAMP/protein kinase A-independent pathway. J Biol Chem. 274:1999;6107-6113.
10. Opthof T. Function and structure of the mouse sinus node: nothing you can see that isn't shown. Cardiovasc Res. 52:2001;1-4.
11. Opthof T., Janse M.J., Breithardt G., Kléber A.G., Kottkamp H., Vanoli E., Study Group 'Experimental Arrhythmia Research' of the Working Group on Arrhythmias of the European Society of Cardiology . The role of basic arrhythmia research: the continued need for experiments in the intact heart and organism. Eur Heart J. 16:1995;1469-1475.
12. Veldkamp M.W., Verkerk A.O., Van Ginneken A.C.G., et al. Norepinephrine induces action potential prolongation and early afterdepolarizations in ventricular myocytes isolated from human end-stage failing hearts. Eur Heart J. 22:2001;955-963.
13. Conrath C.E., Wilde A.A.M., Jongbloed R.J.E., et al. Gender differences in the long QT syndrome. Effects of β-adrenoceptor blockade. Cardiovasc Res. 53:2002;770-776.
14. Dale H.H., Laidlaw P.P., Symons C.T. A reversed action of the vagus on the mammalian heart. J Physiol. 41:1910;1-18.
15. Henning R.J. Vagal stimulation during muscarinic and β-adrenergic blockade increases atrial contractility and heart rate. J Auton Nerv Syst. 40:1992;121-130.
16. Roossien A., Brunsting J.R., Nijmeijer A., Schuil H.A., Zijlstra W.G. Mechanism of the decline in vagal acceleration in dogs in neuroleptanaesthesia. J Auton Nerv Syst. 54:1995;1-8.
17. Opthof T. The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res. 45:2000;177-184.
18. Opthof T., Dekker L.R.C., Coronel R., Vermeulen J.T., Van Capelle F.J.L., Janse M.J. Interaction of sympathetic and parasympathetic stimulation on ventricular refractoriness assessed by local fibrillation intervals in the canine heart. Cardiovasc Res. 27:1993;753-759.
19. 3-adrenoceptor gene. Mol Pharmacol. 44:1993;264-270.
20. Randall W.C., Szentivanyi M., Pace J.B., Echsler J.S., Kaye M.P. Patterns of nerve projections onto the canine heart. Circ Res. 22:1968;315-322.
21. Dahlström A., Fuxe K., Mya-Tu M., Zetterström B.E.M. Observations on adrenergic innervation in the dog heart. Am J Physiol. 209:1965;689-692.
22. Brodde E. β-adrenoceptors in cardiac disease. Pharmacol Ther. 60:1993;405-430.
23. Tavernier G., Galitzky J., Bousquet-Melou A., Montastruc J.L., Berlan M. The positive chronotropic effect induced by BRL 37344, and CGP 12177, two beta-3 adrenoceptor agonists, does not involve cardiac beta adrenoceptors, but baroreflex mechanisms. J Pharmacol Exp Ther. 263:1992;1083-1090.
24. 3 adrenoceptor agonist BRL 35135 in man. Br J Clin Pharmacol. 37:1994;363-369.